id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-S-0036-0149,FDA,FDA-1995-S-0036,"Eunice Kennedy Shriver National Institute of Child Health and Human Development, IND 79,010, Lorazepam, Sites Listed in Abstract, Public Disclosure Material Report 69 Correction Cover Letter re 
FDA-1995-S-0036-0148",Other,Correspondence,2013-09-27T04:00:00Z,2013,9,2013-09-27T04:00:00Z,,2014-11-28T19:46:58Z,,0,0,09000064818679c2
FDA-1995-S-0036-0148,FDA,FDA-1995-S-0036,"Eunice Kennedy Shriver National Institute of Child Health and Human Development, IND 79,010, Lorazepam, Sites Listed in Abstract, Public Disclosure Material Report 69",Other,Report,2013-09-20T04:00:00Z,2013,9,2014-10-24T04:00:00Z,,2014-11-28T19:46:46Z,,0,0,09000064818679c1
FDA-1995-S-0036-0141,FDA,FDA-1995-S-0036,"University of Texas Health Science Center at Houston, IND 14929, Site Medical College of Wisconsin and Maryland School of Medicine, Public Disclosure Material Report 67 - Report",Other,Report,2013-02-28T05:00:00Z,2013,2,2013-02-28T05:00:00Z,,2014-11-28T19:45:09Z,,0,0,09000064811d19f9
FDA-1995-S-0036-0140,FDA,FDA-1995-S-0036,"ICOS Corporation, Community Consultation and Public Disclosure information for Waiver of Informed Consent, BB IND-7371, Public Disclosure of Study Results - Supplement",Other,Supplement (SUP),2013-01-22T05:00:00Z,2013,1,2013-01-22T05:00:00Z,,2021-02-05T19:06:43Z,,0,0,090000648055b01b
FDA-1995-S-0036-0139,FDA,FDA-1995-S-0036,"Baxter, Christiana Hospital, Medical Center of Delaware, INDA#6859, Report 1 -  Report",Other,Report,2013-01-22T05:00:00Z,2013,1,2013-01-22T05:00:00Z,,2021-02-05T19:06:42Z,,0,0,090000648055afd1
FDA-1995-S-0036-0138,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110280, Milwaukee Site Public Disclosure Material Report 66 - Report",Other,Report,2013-01-22T05:00:00Z,2013,1,2013-01-22T05:00:00Z,,2014-11-28T19:44:57Z,,0,0,09000064811bf91d